4.4 Article

Current Advances in the Management of Adult Craniopharyngiomas

期刊

CURRENT ONCOLOGY
卷 29, 期 3, 页码 1645-1671

出版社

MDPI
DOI: 10.3390/curroncol29030138

关键词

craniopharyngiomas; sellar tumors; gross total resection; surgical resection; minimally invasive; neurological complications; radiation therapy; chemotherapy; molecular biology

类别

资金

  1. Secretariat of Education, Science, Technology, and Innovation (SECTEI) of Mexico City
  2. Postdoctoral Scholarship for International Projects

向作者/读者索取更多资源

Craniopharyngiomas are slow-growing, histologically benign intracranial tumors located in the sellar-suprasellar region. They often cause significant neurologic, endocrine, and visual comorbidities due to their location and relationship to adjacent structures. Surgery, radiation, and endocrine management are the main treatment options, while recent advancements in surgical techniques, radiation therapy, and chemotherapy offer potential benefits in tumor resection and growth control.
Craniopharyngiomas (CPs) are slow growing, histologically benign intracranial tumors located in the sellar-suprasellar region. Although known to have low mortality, their location and relationship to the adjacent neural structures results in patients having significant neurologic, endocrine, and visual comorbidities. The invasive nature of this tumor makes complete resection a challenge and contributes to its recurrence. Additionally, these tumors are bimodally distributed, being treated with surgery, and are followed by other adjuncts, such as focused radiation therapy, e.g., Gamma knife. Advances in surgical techniques, imaging tools, and instrumentations have resulted in the evolution of surgery using endoscopic techniques, with residual components being treated by radiotherapy to target the residual tumor. Advances in molecular biology have elucidated the main pathways involved in tumor development and recurrence, but presently, no other treatments are offered to patients, besides surgery, radiation, and endocrine management, as the disease and tumor evolve. We review the contemporary management of these tumors, from the evolution of surgical treatments, utilizing standard open microscopic approaches to the more recent endoscopic surgery, and discuss the current recommendations for care of these patients. We discuss the developments in radiation therapy, such as radiosurgery, being used as treatment strategies for craniopharyngioma, highlighting their beneficial effects on tumor resections while decreasing the rates of adverse outcomes. We also outline the recent chemotherapy modalities, which help control tumor growth, and the immune landscape on craniopharyngiomas that allow the development of novel immunotherapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据